期刊
PHARMACEUTICALS
卷 3, 期 12, 页码 3594-3613出版社
MDPI
DOI: 10.3390/ph3123594
关键词
Cell-Penetrating Peptide (CPP); Cell-Penetrating Penta-peptide (CPP5); Bax Inhibiting Peptide (BIP); Protein Transduction; Ku70; Bax; Apoptosis; Drug Delivery
资金
- National Institutes of Health (NIH) [PC0CA1037, R01AG031903]
- American Heart Association fellowship [0615139B]
- Flow Cytometry and Confocal Microscopy core facilities of the Comprehensive Cancer Center of Case Western Reserve University and University Hospital [P30CA43703]
Previously, we developed cell-penetrating penta-peptides (CPP5s). In the present study, VPTLK and KLPVM, two representative CPP5s, were used to characterize the cellpenetration and protein-transduction activities of these small molecules. Various inhibitors of endocytosis and pinocytosis (chlorpromazine, cytochalasin D, Filipin III, amiloride, methyl-beta-cyclodextrin, and nocodazole) were tested. Only cytochalasin D showed suppression of CPP5 entry, though the effect was partial. In addition, CPP5s were able to enter a proteoglycandeficient CHO cell line. These results suggest that pinocytosis and endocytosis may play only a minor role in the cell entry of CPP5s. By mass spectrometry, we determined that the intracellular concentration of VPTLK ranged from 20 nM to 6.0 mu M when the cells were cultured in medium containing 1 mu M -1.6 mM VPTLK. To determine the protein-transduction activity of CPP5s, the Tex-LoxP EG cell line, which has a Cre-inducible green fluorescent protein (GFP) gene, was used. VPTLK and KLPVM were added to the N-terminus
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据